Mycoplasma bovis : A review of vaccination and diagnostic initiatives
Isaac Dayo Olorunshola,
No information about this author
Kabiru Ahmad,
No information about this author
A.R. Peters
No information about this author
et al.
CABI Reviews,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 26, 2025
Abstract
Mycoplasma
bovis
infections
in
cattle
constitute
a
worldwide
problem
with
significant
detrimental
economic
impacts
on
industry.
Mastitis,
pneumonia,
arthritis,
keratoconjunctivitis,
otitis
media
and
genital
disorders
are
its
clinical
manifestations.
Presently,
no
vaccines
commercially
available;
antimicrobial
resistance
is
increasing;
diagnostic
sensitivity
testing
needs
to
be
improved;
new
rapid
diagnosis
kits
eminent
for
implementation
of
treatment
antimicrobials.
We
conducted
systematic
search
databases
such
as
PubMed,
Scopus,
Web
Science,
Google
Scholar,
AGRIS
African
Journals
Online
(AJOL),
from
1995
2024.
Searched
keywords,
as,
bovis,
M
:
vaccine
development,
techniques
strain
variability
using
the
predefined
criteria
were
used
address
review
objectives.
Although
they
have
preventative
function,
–
killed,
live
attenuated,
subunit
types
face
difficulties
because
M.
strains
vary
widely.
Every
approach
has
own
set
benefits
drawbacks,
those
that
been
studies
include
conventional
culture
identification,
serological
testing,
immunohistochemical
demonstration
tissues,
sophisticated
molecular
like
PCR,
qPCR,
next-generation
sequencing.
For
early
detection,
successful
treatment,
vaccination
efficacy
monitoring,
accurate
crucial.
Future
directions
managing
-associated
diseases
improving
accessibility
creating
broad-spectrum
vaccinations.
By
incorporating
these
developments,
it
may
possible
enhance
health
cattle,
promote
sustainability
livestock
production,
increase
food
security.
This
points
urgent
need
further
research
innovation
advancement
support
Language: Английский
Metagenomic analysis reveals the diversity, transmission and potential ecological risks of yak nasal bacteria-carried antibiotic resistance genes in the Sichuan region of Qinghai-Tibet plateau
Zhao Fang-fang,
No information about this author
Shifeng Wu,
No information about this author
Xiuying Shen
No information about this author
et al.
Journal of Hazardous Materials,
Journal Year:
2025,
Volume and Issue:
494, P. 138476 - 138476
Published: May 8, 2025
Language: Английский
Innovative Methodology for Antimicrobial Susceptibility Determination in Mycoplasma Biofilms
Bryan Tegner Jacobson,
No information about this author
Jessica DeWit-Dibbert,
No information about this author
Eli T. Selong
No information about this author
et al.
Microorganisms,
Journal Year:
2024,
Volume and Issue:
12(12), P. 2650 - 2650
Published: Dec. 20, 2024
Mycoplasma
spp.
are
facultative
pathogens
that
contribute
to
the
pathogenesis
of
multiple
bovine
diseases,
including
respiratory
disease
complex,
and
have
been
shown
form
biofilms.
Biofilm
formation
is
associated
with
increased
antibiotic
resistance
in
many
organisms,
but
accurate
determination
antimicrobial
susceptibility
biofilms
challenging.
In
spp.,
routinely
determined
using
metabolic
pH-dependent
color
change.
However,
biofilm
can
lead
reduced
metabolism,
making
interpretation
readouts
difficult.
Therefore,
we
developed
optimized
a
new
flow
cytometry-based
method
for
testing
biofilm-forming
Mycoplasma,
termed
live/dead
test
(LD-AST).
The
LD-AST
measures
proportion
live
bacteria
upon
exposure
antibiotics,
works
robustly
both
planktonic
cultures,
enables
minimum
bactericidal
concentration
(MBC)
given
antibiotic.
We
used
two
strains
bovis
(Donetta
PG45
Madison)
clinical
bovoculi
isolates
(MVDL1
MVDL2)
determine
impact
growth
on
gentamicin,
enrofloxacin,
or
tetracycline.
All
were
susceptible
all
antibiotics
when
cultured
as
cells,
MBCs
expected
range.
three
out
four
PG45,
MVDL1,
completely
resistant
newly
adhered
analyzed,
whereas
M.
Madison
gave
variable
results.
For
mature
4-5
days
before
exposure,
results
also
variable,
some
showing
an
certain
decreased
others.
Overall,
these
consistent
earlier
reports
exhibit
resistance.
Language: Английский
Public Health Threats Posed by Biofilms and Innovative Strategies for their Control
Syed Hamza Abbas,
No information about this author
Shahzar Khan,
No information about this author
M.J. Shah
No information about this author
et al.
Discoveries,
Journal Year:
2024,
Volume and Issue:
12(4), P. e197 - e197
Published: Dec. 31, 2024
Biofilms
are
communities
of
microorganisms
that
adhere
to
surfaces
within
a
self-produced
protective
matrix.
The
structural
complexity
biofilms
and
their
inherent
resistance
conventional
antimicrobial
treatments
make
them
significant
public
health
challenge.
These
microbial
communities,
embedded
extracellular
matrix,
associated
with
numerous
persistent
infections,
especially
those
occurring
in
healthcare
settings
where
they
colonize
medical
devices
chronic
wounds.
effects
go
beyond
environments
persist
water
treatment
facilities,
food
processing
plants,
nature,
which
aid
pollution
transmission
disease.
This
review
article
discusses
multifaceted
complications
related
the
search
for
existing
control
strategies,
process
biofilm
formation,
mechanisms
persistence,
limitations
traditional
approaches.
Additionally,
this
explores
new
innovative
solutions,
such
as
bacteriophage
therapy,
matrix-degrading
enzymes,
quorum
sensing
inhibitors.
potential
combination
agents
biofilm-disrupting
compounds
improvement
efficacy
is
also
paid
special
attention.
seeks
contribute
these
ongoing
efforts
by
presenting
an
overview
biology
assessing
variety
possible
strategies.
Subsequently,
insights
derived
from
study
may
be
used
inform
future
research
directions
development
more
effective
interventions
biofilm-associated
infections
contamination
various
settings.
Language: Английский